Published in Am J Med Genet on July 15, 1994
Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Psychiatry (2010) 1.79
Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization. J Neurodev Disord (2010) 1.34
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome. Future Neurol (2009) 1.17
Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes. J Clin Invest (1997) 1.04
Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature. Genet Med (2009) 1.04
Associated features in females with an FMR1 premutation. J Neurodev Disord (2014) 0.94
Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet B Neuropsychiatr Genet (2012) 0.89
Behavioral assessment of social anxiety in females with Turner or fragile X syndrome. J Autism Dev Disord (2003) 0.83
Trajectory and Predictors of Depression and Anxiety Disorders in Mothers With the FMR1 Premutation. Biol Psychiatry (2015) 0.80
Chronological age, but not FMRP levels, predicts neuropsychological performance in girls with fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet (2006) 0.80
Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families. Pediatrics (2017) 0.75
Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet (2000) 6.73
Quantitative trait locus for reading disability on chromosome 6. Science (1994) 6.07
ClinQuery: a system for online searching of data in a teaching hospital. Ann Intern Med (1989) 5.13
Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain (2002) 4.05
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain (2005) 3.99
Executive function deficits in high-functioning autistic individuals: relationship to theory of mind. J Child Psychol Psychiatry (1991) 3.18
Protein composition of the intranuclear inclusions of FXTAS. Brain (2005) 2.95
E1a regions of the human adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related. J Virol (1985) 2.59
Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet (2000) 2.46
Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. Am J Med Genet (1991) 2.29
Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet (1999) 2.26
Quantitative-trait locus for specific language and reading deficits on chromosome 6p. Am J Hum Genet (1999) 2.26
Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet (2000) 2.24
FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet (1999) 2.23
Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology (2005) 2.04
Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA (1994) 2.01
Intact and impaired memory functions in autism. Child Dev (1996) 2.00
A comparison of the neuropsychological profiles of the DSM-IV subtypes of ADHD. J Abnorm Child Psychol (2001) 1.97
Understanding of others' intentions in children with autism. J Autism Dev Disord (2001) 1.94
Specific reading disability: identification of an inherited form through linkage analysis. Science (1983) 1.94
Comorbidity of reading disability and attention-deficit/hyperactivity disorder: differences by gender and subtype. J Learn Disabil (2004) 1.92
Genetic influences on learning disabilities and speech and language disorders. Child Dev (1983) 1.90
A comparison of the cognitive deficits in reading disability and attention-deficit/hyperactivity disorder. J Abnorm Psychol (2001) 1.88
Initial cash/asset ratio and asset prices: an experimental study. Proc Natl Acad Sci U S A (1998) 1.87
Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet (2000) 1.85
Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? Pharmacol Ther (2008) 1.85
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology (2007) 1.80
Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology (2007) 1.77
Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet (2004) 1.77
The history of public health and the modern state. Introduction. Clio Med (1994) 1.76
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis (2004) 1.69
High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet (1994) 1.68
Aging in individuals with the FMR1 mutation. Am J Ment Retard (2004) 1.68
Psychiatric comorbidity in children and adolescents with reading disability. J Child Psychol Psychiatry (2000) 1.66
Spelling errors and reading fluency in compensated adult dyslexics. Ann Dyslexia (1991) 1.66
Fluorescence of tryptophan dipeptides: correlations with the rotamer model. Biochemistry (1991) 1.64
Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant (2000) 1.62
Executive function and social communication deficits in young autistic children. J Child Psychol Psychiatry (1993) 1.60
Imitation and pantomime in high-functioning adolescents with autism spectrum disorders. Child Dev (1996) 1.58
Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard (1998) 1.58
Fluorescence properties of pteridine nucleoside analogs as monomers and incorporated into oligonucleotides. Anal Biochem (1997) 1.57
Asperger's syndrome: evidence of an empirical distinction from high-functioning autism. J Child Psychol Psychiatry (1991) 1.57
Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry (1994) 1.53
Sensory modulation dysfunction in children with attention-deficit-hyperactivity disorder. Dev Med Child Neurol (2001) 1.49
Daily relaxation response breaks in a working population: I. Effects on self-reported measures of health, performance, and well-being. Am J Public Health (1977) 1.48
Computerized radiologic reporting with voice data-entry. Radiology (1981) 1.48
Executive functions in young children with autism. Child Dev (1999) 1.45
A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J Med Genet (2001) 1.44
Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav (2012) 1.44
Effect of resistance training on single muscle fiber contractile function in older men. J Appl Physiol (1985) (2000) 1.43
Behavioral and psychiatric disorders in adult male carriers of fragile X. J Am Acad Child Adolesc Psychiatry (1994) 1.42
Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia (1999) 1.42
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav (2012) 1.41
Evolution of T4-related phages. Virus Genes (1995) 1.39
CT detection of cortical fracture of the femoral head associated with posterior hip dislocation. AJR Am J Roentgenol (1990) 1.38
An analysis of autism in fifty males with the fragile X syndrome. Am J Med Genet (1986) 1.38
Quantitative trait locus for reading disability: correction. Science (1995) 1.37
Sensory-modulation disruption, electrodermal responses, and functional behaviors. Dev Med Child Neurol (1999) 1.37
Twin study of the etiology of comorbidity between reading disability and attention-deficit/hyperactivity disorder. Am J Med Genet (2000) 1.36
Evidence for linkage and association with reading disability on 6p21.3-22. Am J Hum Genet (2002) 1.31
Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. Psychoneuroendocrinology (2008) 1.31
Word identification in reading and the promise of subsymbolic psycholinguistics. Psychol Rev (1990) 1.31
Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev (1990) 1.31
Comparing the rheology of native spider and silkworm spinning dope. Nat Mater (2006) 1.30
Energy expenditure during front crawl swimming: predicting success in middle-distance events. Int J Sports Med (1985) 1.30
Collection of a clean voided urine specimen: a comparison among spoken, written, and computer-based instructions. Am J Public Health (1977) 1.29
Are there emotion perception deficits in young autistic children? J Child Psychol Psychiatry (1990) 1.29
Psychiatric comorbidity associated with DSM-IV ADHD in a nonreferred sample of twins. J Am Acad Child Adolesc Psychiatry (1999) 1.28
What was social medicine? An historiographical essay. J Hist Sociol (1988) 1.28
The politics of prevention: anti-vaccinationism and public health in nineteenth-century England. Med Hist (1988) 1.27
Reliability and validity of the adult reading history questionnaire. J Learn Disabil (2004) 1.24
Molecular-clinical correlations in males with an expanded FMR1 mutation. Am J Med Genet (1996) 1.24
The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity. J Dev Behav Pediatr (1993) 1.23
Resistance training improves single muscle fiber contractile function in older women. Am J Physiol Cell Physiol (2001) 1.22
A fluorometric assay for DNA cleavage reactions characterized with BamHI restriction endonuclease. Anal Biochem (1994) 1.21
Hyperactivity and spelling disability: testing for shared genetic aetiology. J Child Psychol Psychiatry (1993) 1.21
Profile of cognitive functioning in women with the fragile X mutation. Neuropsychology (2001) 1.20
Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors. J Biol Chem (1996) 1.19
Cognitive profiles and the spectrum of clinical manifestations in heterozygous fra (X) females. Am J Med Genet (1986) 1.17
A twin study of mathematics disability. J Learn Disabil (1997) 1.16
Using genetics to dissect cognition. Am J Hum Genet (1997) 1.14
Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet B Neuropsychiatr Genet (2010) 1.14
Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.13
The rise of the English drugs industry: the role of Thomas Corbyn. Med Hist (1989) 1.13
Concomitant field terms for asymmetric gradient coils: consequences for diffusion, flow, and echo-planar imaging. Magn Reson Med (2008) 1.12
Evidence that a New Antibiotic Flavone Glycoside Chemically Defends the Sea Grass Thalassia testudinum against Zoosporic Fungi. Appl Environ Microbiol (1998) 1.12
Lignocellulolysis by ascomycetes (fungi) of a saltmarsh grass (smooth cordgrass). Microsc Res Tech (1996) 1.12
Neuropsychological dysfunction among affected heterozygous fragile X females. Am J Med Genet (1990) 1.11
ClinQuery: searching a large clinical database. MD Comput (1990) 1.11
The neuropsychological phenotype in Turner syndrome. Cortex (1985) 1.10
Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis (1999) 1.10
Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports. Br J Cancer (2003) 1.09
Neuropsychological deficits in early treated phenylketonuric children. Am J Ment Defic (1985) 1.08
Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study. Am J Med Genet (2000) 1.08
Mitral valve prolapse and aortic dilatation in the fragile X syndrome. Am J Med Genet (1984) 1.08